Bedaquiline fumarate
- Product Name
- Bedaquiline fumarate
- CAS No.
- 845533-86-0
- Chemical Name
- Bedaquiline fumarate
- Synonyms
- Badaquiline Fumarate;R 403323;TMC207 fumarate;R207910 fumarate;Sirturo fumarate;Bedaquiline Fumarat;TMC-207;TMC207;TMC 207;Bedaquiline (fuMarate);Bedaquinoline fumarate;Bedaquiline Fumarate salt
- CBNumber
- CB92705076
- Molecular Formula
- C36H35BrN2O6
- Formula Weight
- 671.59
- MOL File
- 845533-86-0.mol
Bedaquiline fumarate Property
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- DMSO : 100 mg/mL (148.90 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- form
- Powder
- InChIKey
- ZLVSPMRFRHMMOY-KZDJUSSONA-N
- SMILES
- C(/C(=O)O)=C\C(=O)O.[C@](C1=CC=CC2C=CC=CC1=2)(O)(CCN(C)C)[C@H](C1C=CC=CC=1)C1=CC2C=C(Br)C=CC=2N=C1OC |&1:8,25,r|
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P271Use only outdoors or in a well-ventilated area.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P330Rinse mouth.
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
P362Take off contaminated clothing and wash before reuse.
P403+P233Store in a well-ventilated place. Keep container tightly closed.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- B3491
- Product name
- Bedaquilinefumarate
- Packaging
- 5mg
- Price
- $55
- Updated
- 2021/12/16
- Product number
- CS-2922
- Product name
- Bedaquilinefumarate
- Purity
- 99.98%
- Packaging
- 5mg
- Price
- $60
- Updated
- 2021/12/16
- Product number
- B3491
- Product name
- Bedaquilinefumarate
- Packaging
- 10mg
- Price
- $75
- Updated
- 2021/12/16
- Product number
- B3491
- Product name
- Bedaquilinefumarate
- Packaging
- 10mM(in 1mL DMSO)
- Price
- $80
- Updated
- 2021/12/16
- Product number
- CS-2922
- Product name
- Bedaquilinefumarate
- Purity
- 99.98%
- Packaging
- 10mg
- Price
- $90
- Updated
- 2021/12/16
Bedaquiline fumarate Chemical Properties,Usage,Production
Description
Bedaquiline fumarate (BQF) is an FDA-approved antituberculosis drug that targets the enzyme ATP synthase. It is a fumarate salt prepared from equimolar amounts of bedaquiline and fumaric acid. It can be used in combination therapy for the treatment of multidrug-resistant tuberculosis in the lungs of adults (18 years of age and older). The new BQF microemulsion dosage form of BQF has improved oral bioavailability over the previous formulation, and the BQF microemulsion is cytocompatible with significantly higher cellular uptake than the control group at the highest concentration of 500 μg/ml, which could lead to further use in the effective treatment of multidrug-resistant tuberculosis[1].
Definition
ChEBI: Bedaquiline fumarate is a fumarate salt prepared from equimolar amounts of bedaquiline and fumaric acid. It is used in combination therapy for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria. It has a role as an antitubercular agent and an ATP synthase inhibitor. It contains a bedaquiline(2+).
Clinical Use
Bedaquiline fumarate is a diarylquinone drug developed by Janssen Pharmaceutical which is marketed under the trade name Sirturo ®. The drug, which was approved in 2012 for the treatment of multidrug-resistant tuberculosis (MDR-TB), was developed in partnership with Johnson & Johnson and represents the first new tuberculosis therapy approved in over four decades. Bedaquiline is the first member of a new class of diarylquinone compounds whose mechanism of action inhibits Mycobaterium tuberculosis ATP synthase which deprives bacterium of energy.
Synthesis
Of the relatively few synthetic approaches to bedaquiline (or its fumarate salt) that have been reported, the most likely process-scale route is that described by Porstmann and co-workers from Janssen Pharmaceutical, and this route is outlined in the scheme. The synthesis was initiated by first freebasing commercially available dimethylaminoketone 31 with sodium hydroxide to provide naphthylone 32 in nearly quantitative yield. Subjection of commercially available quinoline 33 to LDA removed the benzyllic proton within this system and subsequent trap with naphthylone 32 gave rise to a mixture of diastereomers whereby the major diastereomer obtained from this reaction corresponded to the bedaquiline geometry. The minor diastereomer was resolved through multiple recrystallizations and seeding techniques. This racemate of the major diastereomer subsequently underwent a chiral resolution upon treatment with BINAP derivative 34 in refluxing DMSO and then upon cooling and subjection to aqueous base in warm toluene furnished bedaquiline 35 bearing the requisite (R,S)- configuration of the two vicinal chiral centers corresponding to that of the drug. The overall yield of the conversion of 33 to enantiopure 35 was 39%. Aminoquinolinol 35 was then prepared as the corresponding fumarate salt upon treatment with fumaric acid in the presence of isopropanol, and this salt formation delivered bedaquiline fumarate (VI) in 82% yield.
Drug interactions
Potentially hazardous interactions with other drugs
Antibacterials: concentration possibly increased
by ciprofloxacin, clarithromycin and erythromycin
- avoid concomitant use if for more than 14 days;
avoid with moxifloxacin; concentration possibly
reduced by rifampicin - avoid; possibly increased risk
of ventricular arrhythmias with clofazimine.
Antiepileptics: concentration possibly reduced by
carbamazepine, fosphenytoin and phenytoin - avoid.
Antivirals: AUC increased by ritonavir, use with
caution, avoid in combination with lopinavir.
Metabolism
Bedaquiline is metabolised mainly by the hepatic CYP3A4 isoenzyme to the N-monodesmethyl metabolite (M2), which is 4-6 times less active than the parent compound. Bedaquiline is excreted mainly in the faeces.
References
[1] VISHWAS P PARDHI. Bedaquiline fumarate microemulsion: formulation optimization, rheological characterization and in vitro studies.[J]. Nanomedicine (London, England), 2022, 17 21: 1529-1546. DOI:10.2217/nnm-2022-0132.
Bedaquiline fumarate Preparation Products And Raw materials
Raw materials
Preparation Products
Bedaquiline fumarate Suppliers
- Tel
- 021-50211651 13651607026
- Fax
- +86-21-50211651
- sales@xxgmpharm.com
- Country
- China
- ProdList
- 493
- Advantage
- 58
- Tel
- 28-83379370 13880556291
- Fax
- 028-87747383
- tcy@tcypharm.com
- Country
- China
- ProdList
- 511
- Advantage
- 57
- Tel
- 0311-85902108 15588346797
- fanbomedical@163.com
- Country
- China
- ProdList
- 236
- Advantage
- 58
- Tel
- 18964309092 18964309092
- 2769493375@qq.com
- Country
- China
- ProdList
- 2635
- Advantage
- 58
- Tel
- 15150528611
- Fax
- 151-5052-8611
- 779881375@qq.com
- Country
- China
- ProdList
- 72
- Advantage
- 58
- Tel
- 028-83379370 13880556291
- Fax
- 028-87747383
- tcy@tcypharm.com
- Country
- China
- ProdList
- 5433
- Advantage
- 58
- Tel
- 025-85566666-7321 15195996671
- API@simcere.com
- Country
- China
- ProdList
- 19
- Advantage
- 58
- Tel
- 19526384105
- 3671394075@qq.com
- Country
- China
- ProdList
- 2452
- Advantage
- 58
- Tel
- 021-021-58432009 400-005-6266
- Fax
- 021-58436166
- sales8178@energy-chemical.com
- Country
- China
- ProdList
- 44751
- Advantage
- 61
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Country
- China
- ProdList
- 4654
- Advantage
- 58
View Lastest Price from Bedaquiline fumarate manufacturers
- Product
- Bedaquiline fumarate 845533-86-0
- Price
- US $32.00-1.40/kg
- Min. Order
- 1kg
- Purity
- 99%
- Supply Ability
- g-kg-tons, free sample is available
- Release date
- 2024-04-07
- Product
- Bedaquiline fumarate 845533-86-0
- Price
- US $0.00-0.00/g
- Min. Order
- 1g
- Purity
- 98%min
- Supply Ability
- 100G
- Release date
- 2021-06-18
- Product
- Bedaquiline (fuMarate) 845533-86-0
- Price
- US $1.00/kg
- Min. Order
- 1kg
- Purity
- 95%-99%
- Supply Ability
- 100kg
- Release date
- 2018-12-20